Question: If my patient is experience and increase in asthmatic symptoms, should it be treated any differently to reduce the risks of COVID 19?

Answer passage (source: CDC):
page_title: Frequently Asked Questions
section_headers: Higher Risk
Are there any medications I should avoid taking if I have COVID-19?
section_content: Currently, there is no evidence to show that taking ibuprofen or naproxen can
lead to a more severe infection of COVID-19.
People with high blood pressure should take their blood pressure medications,
as directed, and work with their healthcare provider to make sure that their
blood pressure is as well controlled as possible. Any changes to your
medications should only be made by your healthcare provider.

Reviewer feedback on this answer:
The question is asking about asthmatic patients and the answer is talking about how ibuprofen is safe to take. This is an answer for a different question making it bad
the response address a totally different entity and left the question asked.

Reviewer ratings:
Bad
Bad

Answer passage (source: CDC):
page_title: Clinical Questions about COVID-19: Questions and Answers
section_headers: Patients with Asthma
If I have patients with asthma, do I need to make any changes to their daily asthma preventive management regimens to reduce their risk of getting sick with COVID-19?
section_content: People with moderate to severe asthma , particularly if not well
controlled, might be at higher risk of getting very sick from COVID-19.
Based on what we currently know about COVID-19, the selection of therapeutic
options through guideline-recommended treatment of asthma has not been
affected. National asthma guidelinesexternal
icon are available. Continuation of inhaled corticosteroids
is particularly important for patients already using these medications because
there is no evidence of increased risk of COVID-19 morbidity with use of
inhaled corticosteroids and an abundance of data showing reduced risk of
asthma exacerbation with maintenance of asthma controller therapy.
Patients with asthma but without symptoms or a diagnosis of COVID-19 should
continue any required nebulizer treatments.

Reviewer feedback on this answer:
The response is precise and straight to the point.
This answer is okay but not great. It mostly says that they should continue with the medication they have. It also talks about their increased risk with some links to supporting information

Reviewer ratings:
Acceptable
Acceptable

Answer passage (source: CDC):
page_title: Clinical Questions about COVID-19: Questions and Answers
section_headers: Patients with Asthma
If my patient experiences an asthma exacerbation, should the exacerbation be treated any differently to reduce risk of COVID-19?
section_content: Selection of therapeutic options through guideline-recommended treatment of
asthma exacerbations has not been affected by what we currently know about
COVID-19.
Systemic corticosteroids should be used to treat an asthma exacerbation per
national asthma guidelinesexternal icon and current standards of
care, even if it is caused by COVID-19. Short-term use of systemic
corticosteroids to treat asthma exacerbations should be continued. There is
currently no evidence to suggest that short-term use of systemic
corticosteroids to treat asthma exacerbations increases the risk of developing
severe COVID-19, whereas there is an abundance of data to support use of
systemic steroids for moderate or severe asthma exacerbations.
Patients with asthma but without symptoms or a diagnosis of COVID-19 should
continue any required nebulizer for treatments, as recommended by national
professional organizations, including the American Academy of Allergy, Asthma
& Immunology (AAAAI) and the American College of Allergy, Asthma & Immunology
(ACAAI). If healthcare providers need to be present during nebulizer use among
patients who have either symptoms or a diagnosis of COVID-19, use CDC’s
recommended precautions when performing aerosol-generating procedures
(AGPs).
Clinicians may be concerned that an asthma exacerbation is related to an
underlying infection with COVID-19. Clinicians can access laboratory testing
for COVID-19 through a network of state and local public health laboratories
across the country. Lists of states and territories with
laboratories that are
using COVID-19 viral tests are available. For more information, see Testing
in U.S. Clinicians
should direct testing questions to their
state
and localexternal icon
health departments.

Reviewer feedback on this answer:
This seems like a very thorough response that hits on exactly what the question is asking. They talk about what to do with patients who have asthma and are or aren't showing COVID symptoms
the question was adequately answer given the content and context of the question

Reviewer ratings:
Excellent
Excellent